Medtronic Statistics
Total Valuation
Medtronic has a market cap or net worth of $103.90 billion. The enterprise value is $124.24 billion.
| Market Cap | 103.90B |
| Enterprise Value | 124.24B |
Important Dates
The next confirmed earnings date is Tuesday, February 18, 2025, before market open.
| Earnings Date | Feb 18, 2025 |
| Ex-Dividend Date | Dec 27, 2024 |
Share Statistics
Medtronic has 1.28 billion shares outstanding. The number of shares has decreased by -1.69% in one year.
| Current Share Class | 1.28B |
| Shares Outstanding | 1.28B |
| Shares Change (YoY) | -1.69% |
| Shares Change (QoQ) | -0.74% |
| Owned by Insiders (%) | 0.05% |
| Owned by Institutions (%) | 84.55% |
| Float | 1.28B |
Valuation Ratios
The trailing PE ratio is 24.81 and the forward PE ratio is 14.22. Medtronic's PEG ratio is 2.32.
| PE Ratio | 24.81 |
| Forward PE | 14.22 |
| PS Ratio | 3.21 |
| Forward PS | 3.00 |
| PB Ratio | 2.14 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 18.90 |
| P/OCF Ratio | 14.44 |
| PEG Ratio | 2.32 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.56, with an EV/FCF ratio of 22.59.
| EV / Earnings | 28.97 |
| EV / Sales | 3.77 |
| EV / EBITDA | 13.56 |
| EV / EBIT | 19.05 |
| EV / FCF | 22.59 |
Financial Position
The company has a current ratio of 1.84, with a Debt / Equity ratio of 0.58.
| Current Ratio | 1.84 |
| Quick Ratio | 1.17 |
| Debt / Equity | 0.58 |
| Debt / EBITDA | 3.00 |
| Debt / FCF | 5.15 |
| Interest Coverage | 8.51 |
Financial Efficiency
Return on equity (ROE) is 8.61% and return on invested capital (ROIC) is 5.30%.
| Return on Equity (ROE) | 8.61% |
| Return on Assets (ROA) | 4.53% |
| Return on Capital (ROIC) | 5.30% |
| Revenue Per Employee | $347,326 |
| Profits Per Employee | $45,137 |
| Employee Count | 95,000 |
| Asset Turnover | 0.37 |
| Inventory Turnover | 2.03 |
Taxes
In the past 12 months, Medtronic has paid $831.00 million in taxes.
| Income Tax | 831.00M |
| Effective Tax Rate | 16.12% |
Stock Price Statistics
The stock price has decreased by -1.27% in the last 52 weeks. The beta is 0.83, so Medtronic's price volatility has been lower than the market average.
| Beta (5Y) | 0.83 |
| 52-Week Price Change | -1.27% |
| 50-Day Moving Average | 86.96 |
| 200-Day Moving Average | 84.37 |
| Relative Strength Index (RSI) | 30.83 |
| Average Volume (20 Days) | 6,276,448 |
Short Selling Information
The latest short interest is 10.18 million, so 0.79% of the outstanding shares have been sold short.
| Short Interest | 10.18M |
| Short Previous Month | 10.67M |
| Short % of Shares Out | 0.79% |
| Short % of Float | 0.80% |
| Short Ratio (days to cover) | 2.19 |
Income Statement
In the last 12 months, Medtronic had revenue of $33.00 billion and earned $4.29 billion in profits. Earnings per share was $3.27.
| Revenue | 33.00B |
| Gross Profit | 21.58B |
| Operating Income | 6.52B |
| Pretax Income | 4.81B |
| Net Income | 4.29B |
| EBITDA | 9.16B |
| EBIT | 6.52B |
| Earnings Per Share (EPS) | $3.27 |
Balance Sheet
The company has $7.99 billion in cash and $28.33 billion in debt, giving a net cash position of -$20.34 billion or -$15.86 per share.
| Cash & Cash Equivalents | 7.99B |
| Total Debt | 28.33B |
| Net Cash | -20.34B |
| Net Cash Per Share | -$15.86 |
| Equity (Book Value) | 48.72B |
| Book Value Per Share | 37.81 |
| Working Capital | 10.24B |
Cash Flow
In the last 12 months, operating cash flow was $7.20 billion and capital expenditures -$1.70 billion, giving a free cash flow of $5.50 billion.
| Operating Cash Flow | 7.20B |
| Capital Expenditures | -1.70B |
| Free Cash Flow | 5.50B |
| FCF Per Share | $4.29 |
Margins
Gross margin is 65.40%, with operating and profit margins of 19.77% and 13.00%.
| Gross Margin | 65.40% |
| Operating Margin | 19.77% |
| Pretax Margin | 15.62% |
| Profit Margin | 13.00% |
| EBITDA Margin | 27.77% |
| EBIT Margin | 19.77% |
| FCF Margin | 16.67% |
Dividends & Yields
This stock pays an annual dividend of $2.80, which amounts to a dividend yield of 3.46%.
| Dividend Per Share | $2.80 |
| Dividend Yield | 3.46% |
| Dividend Growth (YoY) | 1.45% |
| Years of Dividend Growth | 48 |
| Payout Ratio | 85.73% |
| Buyback Yield | 1.69% |
| Shareholder Yield | 5.14% |
| Earnings Yield | 4.13% |
| FCF Yield | 5.29% |
Analyst Forecast
The average price target for Medtronic is $93.67, which is 15.60% higher than the current price. The consensus rating is "Hold".
| Price Target | $93.67 |
| Price Target Difference | 15.60% |
| Analyst Consensus | Hold |
| Analyst Count | 16 |
| Revenue Growth Forecast (5Y) | 4.95% |
| EPS Growth Forecast (5Y) | 21.33% |
Stock Splits
The last stock split was on September 27, 1999. It was a forward split with a ratio of 2:1.
| Last Split Date | Sep 27, 1999 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Medtronic has an Altman Z-Score of 2.81 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.81 |
| Piotroski F-Score | 5 |